FDA allows marketing of first-of-kind tissue containment system for use with certain laparoscopic power morcellators in select ...
The U.S. Food and Drug Administration today permitted the marketing of PneumoLiner, the first tissue containment system for use with certain laparoscopic power morcellators to isolate uterine tissue that is not suspected to contain cancer. Although the …